Ilsung Is Co., Ltd. (KRX:003120)

South Korea · Delayed Price · Currency is KRW

22,000

+350 (1.62%)

Sep 11, 2026, 3:30 PM KST

Market Cap	153.32B -12.5%
Revenue (ttm)	65.22B -5.2%
Net Income	5.54B -52.2%
EPS	n/a
Shares Out	6.97M
PE Ratio	27.66
Forward PE	n/a
Dividend	1,500.00 (7.30%)
Ex-Dividend Date	Dec 29, 2025

Volume	3,918
Open	21,650
Previous Close	21,650
Day's Range	21,550 - 22,000
52-Week Range	17,120 - 29,300
Beta	-0.19
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Ilsung Is

Ilsung Is Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, antipyretic-analgesics, antihistamine, neuropsychiatric, neuromuscular blocker/ central muscle relaxants, anti-coagulants, probiotics, vaccine, medical equipment, circulatory system drugs, contrast agents, muscle relaxants, diabetes treatments, osteopathic, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, adrenal cortical steroids, anesthetics, antipyretics, and cardiovascular sys... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1954

Country South Korea

Stock Exchange Korea Stock Exchange

Ticker Symbol 003120

Full Company Profile

Financial Performance

In 2025, Ilsung Is's revenue was 64.29 billion, a decrease of -6.85% compared to the previous year's 69.02 billion. Earnings were 1.17 billion, a decrease of -91.10%.

Financial Statements